Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Achieve Life Sciences (ACHV) shares

Learn how to easily invest in Achieve Life Sciences shares.

Achieve Life Sciences is a biotechnology business based in the US. Achieve Life Sciences stocks (ACHV.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $8 – a decrease of 6.45% over the previous week. Achieve Life Sciences employs 13 staff and has a market cap (total outstanding stock value) of $79.1 million.

How to buy shares in Achieve Life Sciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ACHV – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Achieve Life Sciences stock price (NASDAQ:ACHV)

Use our graph to track the performance of ACHV stocks over time.

Achieve Life Sciences shares at a glance

Information last updated 2022-01-17.
Latest market close$7.83
52-week range$6.55 - $16.10
50-day moving average $7.73
200-day moving average $8.38
Wall St. target price$31.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-4.50

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Achieve Life Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Achieve Life Sciences price performance over time

Historical closes compared with the close of $7.83 from 2022-01-21

1 week (2022-01-13) -5.09%
1 month (2021-12-18) N/A
3 months (2021-10-18) N/A
6 months (2021-07-22) 1.16%
1 year (2021-01-22) -33.53%
2 years (2020-01-22) 1,212.66%
3 years (2019-01-22) 506.98%
5 years (2017-01-20) 1,336.70%

Achieve Life Sciences financials

Gross profit TTM $0
Return on assets TTM -58.66%
Return on equity TTM -101.78%
Profit margin 0%
Book value $3.67
Market capitalisation $79.1 million

TTM: trailing 12 months

Achieve Life Sciences share dividends

We're not expecting Achieve Life Sciences to pay a dividend over the next 12 months.

Have Achieve Life Sciences's shares ever split?

Achieve Life Sciences's shares were split on a 1:20 basis on 30 July 2020. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Achieve Life Sciences shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Achieve Life Sciences shares which in turn could have impacted Achieve Life Sciences's share price.

Achieve Life Sciences share price volatility

Over the last 12 months, Achieve Life Sciences's shares have ranged in value from as little as $6.55 up to $16.1. A popular way to gauge a stock's volatility is its "beta".

ACHV.US volatility(beta: 1.24)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Achieve Life Sciences's is 1.2362. This would suggest that Achieve Life Sciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Achieve Life Sciences overview

Achieve Life Sciences, Inc. , a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site